Chorionic Gonadotropin Market By Type (Human Chorionic Gonadotropin (HCG), Animal Chorionic Gonadotropin), By Application (Research institutions, Pharmaceutical), By technology (Natural source extraction, Recombinant DNA technology), By therapeutic area (Female infertility treatment, Oligospermia treatment, Cryptorchidism treatment), Industry Trends, Estimation & Forecast, 2017-2025

Check Today's Best Price

$3500 Buy Now
Chorionic Gonadotropin Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.
  • Market Overview:

    Chorionic gonadotropin is similar to luteinizing hormone (LH) in function, which is secreted by placenta while the embryo is developing during the pregnancy. This hormone, when administrated with combination of other drugs, helps women to conceive. Apart from that, chorionic gonadotropin along with LH stimulates the production of testosterone in males.

    Increasing infertility rates worldwide is the major factor which is driving the growth of chorionic gonadotropin market. As per the statistics declared by Maternal Health Task Force, today, infertility is experienced by approximately 50 million couples all around the world. Other factors which are contributing to the market growth include changing lifestyle, increasing maternity age, oligospermia, hormonal dysfunctions in both men and women, and tilting orientation of people towards hormonal drug therapies. Moreover, it has also been found that the reproductive performance of veterinary animals is also improved by the clinical use of chorionic gonadotropin extracted from human origin. For example Chorulon®, which contains the complex glycoprotein, is used in the treatment of cattle, horses, dogs, goats, pigs and queen cats for improving conception and other reproductive ailments. However, substitutes to chorionic gonadotropin treatment such as insemination and in vitro fertilization (IVF) are the challenges which can obstruct the growth of the chorionic gonadotropin market.

    The report provides detailed qualitative and quantitative analysis of the chorionic gonadotropin market. Market size and forecast in terms of value and volume has been provided for the period – (2018 – 2025), for the segments namely type, application, technology, therapeutic area in each of the major regions.

    Chorionic Gonadotropin Market Segmentation

    By Type
    • Human Chorionic Gonadotropin (HCG)
    • Animal Chorionic Gonadotropin

    By Application
    • Research institutions
    • Pharmaceutical
    • Others

    By technology 
    • Natural source extraction
    • Recombinant DNA technology

    By therapeutic area 
    • Female infertility treatment
    • Oligospermia treatment
    • Cryptorchidism treatment
    • Others

    By geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1.INTRODUCTION
    1.1.RESEARCH METHODOLOGY
    1.1.1.ERC desk research
    1.1.2.ERC data synthesis
    1.1.3.Data validation and market feedback
    1.1.4.ERC data sources

    CHAPTER 2.CHORIONIC GONADOTROPIN MARKET OVERVIEW
    2.1.CHORIONIC GONADOTROPIN MARKET INTRODUCTION
    2.2.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1.Global Chorionic Gonadotropin Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3.GLOBAL CHORIONIC GONADOTROPIN MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1.Global Chorionic Gonadotropin Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1.Global Chorionic Gonadotropin Consumption (VOLUME) and Growth Rate (%), (2017-2025)

    CHAPTER 3.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TYPE, 2017-2025
    3.1.HUMAN CHORIONIC GONADOTROPIN (HCG)
    3.2.ANIMAL CHORIONIC GONADOTROPIN
    3.3.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY TYPE, 2017-2025
    3.3.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Type, 2017-2025
    3.3.2.Human Chorionic Gonadotropin (HCG) Market Revenue and Growth Rate, 2017-2025
    3.3.3.Animal Chorionic Gonadotropin Market Revenue and Growth Rate, 2017-2025
    3.4.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION BY TYPE, 2017-2025
    3.4.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Type, 2017-2025
    3.4.2.Human Chorionic Gonadotropin (HCG) Market Production and Growth Rate, 2017-2025
    3.4.3.Animal Chorionic Gonadotropin Market Production and Growth Rate, 2017-2025

    CHAPTER 4.GLOBAL CHORIONIC GONADOTROPIN MARKET BY APPLICATION, 2017-2025
    4.1.RESEARCH INSTITUTIONS
    4.2.PHARMACEUTICAL
    4.3.OTHERS
    4.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2.Research institutions Market Revenue and Growth Rate, 2017-2025
    4.4.3.Pharmaceutical Market Revenue and Growth Rate, 2017-2025
    4.4.4.Others Market Revenue and Growth Rate, 2017-2025
    4.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1.Global Chorionic Gonadotropin Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2.Research institutions Market Consumption and Growth Rate, 2017-2025
    4.5.3.Pharmaceutical Market Consumption and Growth Rate, 2017-2025
    4.5.4.Others Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TECHNOLOGY, 2017-2025
    5.1.NATURAL SOURCE EXTRACTION
    5.2.RECOMBINANT DNA TECHNOLOGY

    CHAPTER 6.GLOBAL CHORIONIC GONADOTROPIN MARKET BY THERAPEUTIC AREA, 2017-2025
    6.1.FEMALE INFERTILITY TREATMENT
    6.2.OLIGOSPERMIA TREATMENT
    6.3.CRYPTORCHIDISM TREATMENT
    6.4.OTHERS

    CHAPTER 7.GLOBAL CHORIONIC GONADOTROPIN MARKET BY REGION, 2017-2025
    7.1.NORTH AMERICA
    7.1.1.U.S.
    7.1.2.Canada
    7.1.3.Mexico
    7.2.EUROPE
    7.2.1.U.K.
    7.2.2.France
    7.2.3.Germany
    7.2.4.Italy
    7.2.5.Spain
    7.2.6.Rest of Europe
    7.3.ASIA PACIFIC
    7.3.1.China
    7.3.2.Japan
    7.3.3.India
    7.3.4.Korea
    7.3.5.Rest of APAC
    7.4.SOUTH AMERICA
    7.4.1.Brazil
    7.4.2.Rest of South America
    7.5.REST OF THE WORLD
    7.5.1.Middle East
    7.5.2.Africa
    7.6.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY REGION, 2017-2025
    7.6.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    7.6.2.North America Market Revenue and Growth Rate, 2017-2025
    7.6.3.Europe Market Revenue and Growth Rate, 2017-2025
    7.6.4.Asia Pacific Market Revenue and Growth Rate, 2017-2025
    7.6.5.South America Market Revenue and Growth Rate, 2017-2025
    7.6.6.Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 8.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    8.1.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    8.1.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Region, 2017-2025
    8.1.2.Global Chorionic Gonadotropin Market Consumption (Volume) and Share (%) By Region, 2017-2025
    8.1.3.North America Market Production and Consumption, 2017-2025
    8.1.4.Europe Market Production and Consumption, 2017-2025
    8.1.5.Asia Pacific Market Production and Consumption, 2017-2025
    8.1.6.South America Market Production and Consumption, 2017-2025
    8.1.7.Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 9.MARKET DETERMINANTS
    9.1.MARKET DRIVERS
    9.2.MARKET RESTRAINTS
    9.3.MARKET OPPORTUNITIES
    9.4.MARKET DETERMINANTS RADAR CHART

    CHAPTER 10.GLOBAL CHORIONIC GONADOTROPIN MARKET COMPETITION BY MANUFACTURERS
    10.1.GLOBAL CHORIONIC GONADOTROPIN PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    10.1.1.Global Chorionic Gonadotropin Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    10.2.GLOBAL CHORIONIC GONADOTROPIN REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    10.2.1.Global Chorionic Gonadotropin Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    10.3.CHORIONIC GONADOTROPIN MARKET COMPETITIVE SITUATION AND TRENDS
    10.3.1.Chorionic Gonadotropin Market Share (%) of Top 3 Manufacturers
    10.3.2.Chorionic Gonadotropin Market Share (%) of Top 5 Manufacturers

    CHAPTER 11.GLOBAL CHORIONIC GONADOTROPIN MANUFACTURERS ANALYSIS
    11.1.EMD SERONO, INC.
    11.1.1.Business Overview
    11.1.2.Company Basic Information
    11.1.3.Chorionic Gonadotropin Product Details
    11.1.4.EMD Serono, Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.2.FERRING B.V.
    11.2.1.Business Overview
    11.2.2.Company Basic Information
    11.2.3.Chorionic Gonadotropin Product Details
    11.2.4.Ferring B.V. Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.3.MERCK & CO., INC.
    11.3.1.Business Overview
    11.3.2.Company Basic Information
    11.3.3.Chorionic Gonadotropin Product Details
    11.3.4.Merck & Co., Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.4.BRISTOL MYERS SQUIBB COMPANY
    11.4.1.Business Overview
    11.4.2.Company Basic Information
    11.4.3.Chorionic Gonadotropin Product Details
    11.4.4.Bristol Myers Squibb Company Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.5.FRESENIUS KABIUSA, LLC.
    11.5.1.Business Overview
    11.5.2.Company Basic Information
    11.5.3.Chorionic Gonadotropin Product Details
    11.5.4.Fresenius KabiUSA, LLC. Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.6.SCRIPPSLABS
    11.6.1.Business Overview
    11.6.2.Company Basic Information
    11.6.3.Chorionic Gonadotropin Product Details
    11.6.4.Scrippslabs Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.7.LEEBIO
    11.7.1.Business Overview
    11.7.2.Company Basic Information
    11.7.3.Chorionic Gonadotropin Product Details
    11.7.4.Leebio Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.8.KAMIYA BIOMEDICAL COMPANY
    11.8.1.Business Overview
    11.8.2.Company Basic Information
    11.8.3.Chorionic Gonadotropin Product Details
    11.8.4.Kamiya Biomedical Company Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.9.CIGNA
    11.9.1.Business Overview
    11.9.2.Company Basic Information
    11.9.3.Chorionic Gonadotropin Product Details
    11.9.4.Cigna Chorionic Gonadotropin Production, Revenue and Gross Margin
    11.10.SANZYME
    11.10.1.Business Overview
    11.10.2.Company Basic Information
    11.10.3.Chorionic Gonadotropin Product Details
    11.10.4.Sanzyme Chorionic Gonadotropin Production, Revenue and Gross Margin

    keyboard_arrow_up
  • • EMD Serono, Inc.
    • Ferring B.V.
    • Merck & Co., Inc.
    • Bristol Myers Squibb Company
    • Fresenius KabiUSA, LLC.
    • Scrippslabs
    • Leebio
    • Kamiya Biomedical Company
    • Cigna
    • Sanzyme

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Chorionic Gonadotropin Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Chorionic Gonadotropin Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS

SHARE YOUR CART